Compound Summary
Compound Information
altretamine
Compound Name: | altretamine |
Compound CID: | 2123 |
Synonyms: | altretamine 645-05-6 HEXAMETHYLMELAMINE Hexalen Hexastat More... |
Iupac Name: | 2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine |
InChI: | InChI=1S/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H3 |
InChIKey: | UUVWYPNAQBNQJQ-UHFFFAOYSA-N |
Canonical Smiles: | CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C |
Isomeric Smiles: | CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C |
Molecular Weight: | 210.28 |
Molecular Formula: | C9H18N6 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
altretamine
Molecular Weight: | 210.28 |
Molecular Formula: | C9H18N6 |
Hydrogen Bond Donor Count: | 0 |
Hydrogen Bond Acceptor Count: | 6 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 15 |
Complexity: | 148 |
Synonyms
altretamine
| altretamine | altretamine |
|---|---|
altretamine |
645-05-6 |
HEXAMETHYLMELAMINE |
Hexalen |
Hexastat |
Hemel |
2,4,6-Tris(dimethylamino)-1,3,5-triazine |
Melamine, hexamethyl- |
Altretaminum |
Altretamina |
Altretaminum INN-Latin |
N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine |
ENT 50852 |
NC 195 |
2,4,6-Tris(dimethylamino)-s-triazine |
NCI-C50259 |
HMM |
Altretamine (Hexalen) |
NSC 13875 |
HTM |
HXM |
s-Triazine, 2,4,6-tris(dimethylamino)- |
UNII-Q8BIH59O7H |
1,3,5-Triazine-2,4,6-triamine, N,N,N,N,N,N-hexamethyl- |
2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine |
MLS000069621 |
N,N,N,N,N,N-hexamethyl-1,3,5-triazine-2,4,6-triamine |
NSC13875 |
NSC-13875 |
Q8BIH59O7H |
SMR000058181 |
645-05-6 (free base) |
CHEBI:24564 |
NCGC00015100-02 |
DSSTox_CID_2579 |
DSSTox_RID_76641 |
DSSTox_GSID_22579 |
ENT-50852;RB-1515;WR-95704 |
Altretamina INN-Spanish |
C9H18N6 |
CAS-645-05-6 |
Hexalen (TN) |
CCRIS 5492 |
SR-01000000117 |
Hexalen Antineoplastic |
Altretamine (USP/INN) |
EINECS 211-428-4 |
BRN 0195058 |
AI3-50852 |
HSDB 7559 |
Altretamine, solid |
Altretamine USAN:USP:INN:BAN |
KB-913 |
Spectrum_001308 |
Opera_ID_1095 |
Prestwick0_000946 |
Prestwick1_000946 |
Prestwick2_000946 |
Prestwick3_000946 |
Spectrum2_000907 |
Spectrum3_000951 |
Spectrum4_001064 |
Spectrum5_001092 |
Lopac-A-8723 |
ChemDiv2_005185 |
2,4, 6-Tris(dimethylamino)-1,3,5-triazine |
A 8723 |
N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine |
Cambridge id 5148727 |
cid_2123 |
SCHEMBL4206 |
CHEMBL1455 |
Lopac0_000083 |
BSPBio_000912 |
KBioGR_001388 |
KBioSS_001788 |
ZINC905 |
MLS001076123 |
DivK1c_000772 |
SPECTRUM1503065 |
SPBio_000754 |
SPBio_003071 |
BPBio1_001004 |
GTPL7112 |
DTXSID4022579 |
BDBM37631 |
HMS502G14 |
KBio1_000772 |
KBio2_001788 |
KBio2_004356 |
KBio2_006924 |
KBio3_002042 |
NINDS_000772 |
BCPP000413 |
HMS1383L15 |
HMS1570N14 |
HMS1922C05 |
HMS2090G17 |
HMS2092H16 |
HMS2097N14 |
HMS2234F09 |
HMS3259I20 |
HMS3260A08 |
HMS3372H17 |
HMS3654H11 |
HMS3714N14 |
Pharmakon1600-01503065 |
1,3,5-Triazine-2,4,6-triamine, N,N,N,N,N,N-hexamethyl- |
BCP27675 |
CCG-2238 |
HY-B0181 |
2,6-Tris(dimethylamino)-s-triazine |
Tox21_110085 |
Tox21_202784 |
Tox21_500083 |
ENT-50852 |
MFCD00549245 |
NSC758231 |
s1278 |
STK749184 |
s-Triazine,4,6-tris(dimethylamino)- |
AKOS001729401 |
Tox21_110085_1 |
BCP9000278 |
CS-2061 |
DB00488 |
KS-5247 |
LP00083 |
MCULE-1605383293 |
NC00595 |
NSC-758231 |
RB-1515 |
SB73671 |
SDCCGSBI-0050071.P004 |
VA10242 |
IDI1_000772 |
IDI1_003900 |
NCGC00015100-01 |
NCGC00015100-03 |
NCGC00015100-04 |
NCGC00015100-05 |
NCGC00015100-06 |
NCGC00015100-07 |
NCGC00015100-08 |
NCGC00015100-09 |
NCGC00015100-10 |
NCGC00015100-11 |
NCGC00015100-12 |
NCGC00015100-14 |
NCGC00015100-15 |
NCGC00015100-23 |
NCGC00021216-03 |
NCGC00021216-04 |
NCGC00021216-05 |
NCGC00021216-06 |
NCGC00021216-07 |
NCGC00260330-01 |
NCGC00260768-01 |
AC-12006 |
CAS-654-05-6 |
NCI60_000871 |
ST086739 |
WR-95704 |
2,6-Tris(dimethylamino)-1,3,5-triazine |
SBI-0050071.P003 |
AB0007992 |
DB-054676 |
AB00052308 |
EU-0100083 |
FT-0651499 |
SW102053-5 |
C76020 |
D02841 |
49712-EP2295426A1 |
49712-EP2295427A1 |
49712-EP2308833A2 |
49712-EP2311825A1 |
AB00052308-16 |
AB00052308-17 |
AB00052308-18 |
AB00052308_19 |
AB00052308_20 |
645A056 |
A834788 |
Q415242 |
WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1 |
2,4,6-Tris(dimethylamino)-1,3,5-triazine, 96% |
J-523408 |
SR-01000000117-2 |
SR-01000000117-4 |
SR-01000000117-6 |
BRD-K67043667-001-04-1 |
BRD-K67043667-001-15-7 |
Z57931197 |
4,6-bis(dimethylamino)(1,3,5-triazin-2-yl)dimethylamine |
N2,N2,N4,N4,N6,N6-Hexamethyl-1,3,5-trazne-2,4,6-tramne |
1,5-Triazine-2,4,6-triamine, N,N,N,N,N,N-hexamethyl- |
Altretamine, United States Pharmacopeia (USP) Reference Standard |
N-4,6-bis(dimethylamino)-1,3,5-triazin-2-yl-N,N-dimethylamine |
1,3,5-Triazine-2,4,6-triamine, N,N,N,N,N, N-hexamethyl-" |
Experimental Data
altretamine
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -14 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
altretamine
Statistics Data
altretamine
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -14 | 1 | 1 |
Statistics Data Visualization
altretamine
